VetStem Biopharma
PrivateLast Round
Strategic
Mar 18, 2025
Total Funding Raised
$2.55M
Company Overview
VetStem Biopharma operates in Healthcare & Life Sciences and is based in Poway, California. Its latest recorded funding round was a Strategic round in March 2025.
VetStem Biopharma is a biotechnology company that provides regenerative stem cell services and therapies for cats, dogs, and horses.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VetStem Biopharma Comparables
Compare VetStem Biopharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Personalized Stem Cells, Inc. | 93% | |
| Ardent Animal Health | 88% | |
| Animal Cell Therapies, Inc. | 87% |
For institutional investors. Book with your work email.
VetStem Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Mar 18, 2025 | ||||
| Debt | Apr 16, 2020 |
For institutional investors. Book with your work email.
VetStem Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Toucan Capital Corporation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Monthly visitors increased 40% MoM.
- May 4, 2025
Monthly visitors grew 50% MoM.
For institutional investors. Book with your work email.
VetStem Biopharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VetStem Biopharma's valuation, stock price, and market status.
Is VetStem Biopharma a public or private company?
VetStem Biopharma is a private company.
What is the current stock price of VetStem Biopharma?
VetStem Biopharma is a private company, so its shares have no public market price. Caplight tracks VetStem Biopharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VetStem Biopharma worth (valuation)?
Valuation information for VetStem Biopharma is not publicly available.
Can I buy VetStem Biopharma stock?
VetStem Biopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VetStem Biopharma's last funding round?
VetStem Biopharma's most recent funding round was Strategic on March 18, 2025.
Who are the main investors in VetStem Biopharma?
Key investors in VetStem Biopharma include Toucan Capital Corporation.
Will VetStem Biopharma IPO soon?
No public IPO plans have been announced for VetStem Biopharma.
How can I track VetStem Biopharma secondary market activity?
Caplight tracks bids, offers, and trades in VetStem Biopharma's shares on secondary markets.